IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.

RTTNews | 527 hari yang lalu

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).

RTTNews | 709 hari yang lalu

Asian Shares Mostly Lower On Trade Tensions, Weak China Data

Asian stocks ended mostly lower on Thursday, with the Federal Reserve's interest-rate decision, tech earnings, U.S. President Donald Trump's tariff threats and China data in focus.

RTTNews | 33 minit yang lalu

South Korean Won Recovers Vs. U.S. Dollar After US-South Korea Trade Deal

The South Korean won recovered from recent loss against the U.S. dollar in the Asian session on Thursday, following the completion of a trade agreement between Seoul and Washington.

RTTNews | 1j 7min yang lalu

Bank Of Japan Keeps Rate On Hold; Lifts Inflation Forecast On Rising Food Prices

The Bank of Japan maintained its interest rate but lifted its inflation outlook due to rising food prices, which had added expectations of an rate hike as soon as in October. The policy board unanimously decided to hold the uncollateralized overnight call rate to remain at around 0.5 percent.

RTTNews | 1j 41min yang lalu